AMRUTANJAN HEALTH CARE
|
|
BOM : 590006     NSE : AMRUTANJAN     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
Aug 10,2022 |
Price(EOD): ₹ 815.35
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 2,380.82 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
AMRUTANJAN HEALTH CARE | 0.9% | 4.8% | 19.3% |
SUN PHARMACEUTICAL INDUSTRIES | 2.5% | 7.3% | 16% |
DIVIS LABORATORIES | 3.2% | 5.7% | -20.7% |
DR REDDYS LABORATORIES | 3.6% | -5.8% | -11.6% |
CIPLA | 2.7% | 9.7% | 13% |
GLAND PHARMA | 1.9% | -7.6% | -41.8% |
PIRAMAL ENTERPRISES | 4% | 3.3% | -32.8% |
CADILA HEALTHCARE | 5.3% | -1.6% | -38.5% |
TORRENT PHARMACEUTICALS | 1.8% | 4% | 1.7% |
FUNDAMENTAL ANALYSIS OF AMRUTANJAN HEALTH CARE
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF AMRUTANJAN HEALTH CARE
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
38.96
P/E Calculated based on EPS of 20.93
[ Mar2021 - Standalone Results ] 11.09
P/B Calculated based on Book Value of 73.53
[ Mar2021 - Standalone Results ] 5.87
P/S Calculated based on Revenues of 405.843 Cr
[ TTM - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
107% 137% 194% |
SHARE PRICE MOMENTUM OF AMRUTANJAN HEALTH CARE
AMRUTANJAN HEALTH CARE vs SENSEX
DEBT OF AMRUTANJAN HEALTH CARE
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
0 0 0 - |
- - - - |
[Last Annual Data : Mar2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF AMRUTANJAN HEALTH CARE
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Jun2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF AMRUTANJAN HEALTH CARE
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-3.74% -36.18% -28.29% -28.54% |
13.33% 32.01% 46% 43.77% |
QtrlyTrend |
0 | |
Latest Qtr: Mar2022 | ||
Quarterly Result Analysis → |
AMRUTANJAN HEALTH CARE related INDICES
You may also like the below Video Courses
FAQ about AMRUTANJAN HEALTH CARE
Is AMRUTANJAN HEALTH CARE good for long term investment?
As on Aug 10,2022, the Fundamentals of AMRUTANJAN HEALTH CARE look Strong and hence it may be good for long term investment! See Financial Performance of AMRUTANJAN HEALTH CARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is AMRUTANJAN HEALTH CARE UnderValued or OverValued?
As on Aug 10,2022, AMRUTANJAN HEALTH CARE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of AMRUTANJAN HEALTH CARE ?
As on Aug 10,2022, the Intrinsic Value of AMRUTANJAN HEALTH CARE is Rs. 344.27 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 393.26
Fair Value [Median EV / Sales Model] : Rs. 344.27
Fair Value [Median Price / Sales Model] : Rs. 276.97
Median Fair Value of AMRUTANJAN HEALTH CARE : Rs. 344.27
Is AMRUTANJAN HEALTH CARE trading at a Premium or Discount?
As on Aug 10,2022, AMRUTANJAN HEALTH CARE is trading at a Premium of 137% based on the estimates of Median Intrinsic Value!SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
